학술논문
Nonclinical pharmacology and toxicology of the first biosimilar insulin glargine drug product (BASAGLAR® /ABASAGLAR® ) approved in the European Union
Document Type
Article
Author
Source
In: Regulatory Toxicology and Pharmacology . (Regulatory Toxicology and Pharmacology, August 2017, 88:56-65)
Subject
Language
English
ISSN
10960295
02732300
02732300